How Climate Shapes the Functioning of Tropical Montane Cloud Forests

This is the author accepted manuscript. The final version is available from Springer via the DOI in this recordPurpose of Review: Tropical Montane Cloud Forest (TMCF) is a highly vulnerable ecosystem, which occurs at higher elevations in tropical mountains. Many aspects of TMCF vegetation functioning are poorly understood, making it difficult to quantify and project TMCF vulnerability to global change. We compile functional traits data to provide an overview of TMCF functional ecology. We use numerical models to understand the consequences of TMCF functional composition with respect to its responses to climate and link the traits of TMCF to its environmental conditions. Recent Findings: TMCF leaves are small and have low SLA but high Rubisco content per leaf area. This implies that TMCF maximum net leaf carbon assimilation (An) is high but often limited by low temperature and leaf wetting. Cloud immersion provides important water and potentially nutrient inputs to TMCF plants. TMCF species possess low sapwood specific conductivity, which is compensated with a lower tree height and higher sapwood to leaf area ratio. These traits associated with a more conservative stomatal regulation results in a higher hydraulic safety margin than nearby forests not affected by clouds. The architecture of TMCF trees including its proportionally thicker trunks and large root systems increases tree mechanical stability. Summary: The TMCF functional traits can be conceptually linked to its colder and cloudy environment limiting An, growth, water transport and nutrient availability. A hotter climate would drastically affect the abiotic filters shaping TMCF communities and potentially facilitate the invasion of TMCF by more productive lowland species.Newton FundNatural Environment Research Council (NERC)FAPES

Evaluation of different total leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a toll-like receptor-3 agonist to prevent cutaneous leishmaniasis

Unfortunately, no any vaccine against leishmaniasis has been developed for human use. Therefore, a vaccine based on total Leishmania antigens could be a good and economic approach; and there are different methodologies to obtain these antigens. However, it is unknown whether the method to obtain the antigens affects the integrity and immune response caused by them. OBJECTIVES: to compare the protein profile and immune response generated by total L. amazonensis antigens (TLA) produced by different methods, as well as to analyse the immune response and protection by a first-generation vaccine formulated with sonicated TLA (sTLA) and polyinosinic:polycytidylic acid [Poly (I:C)]. METHODS: TLA were obtained by four different methodologies and their integrity and immune response were evaluated. Finally, sTLA was formulated with Poly (I:C) and their protective immune response was measured. FINDINGS: sTLA presented a conserved protein profile and induced a strong immune response. In addition, Poly (I:C) improved the immune response generated by sTLA. Finally, sTLA + Poly (I:C) formulation provided partial protection against L. amazonensis infection. MAIN CONCLUSIONS: The protein profile and immune response depend on the methodology used to obtain the antigens. Also, the formulation sTLA + Poly (I:C) provides partial protection against cutaneous leishmaniasis in mice.Fil: Germano, Maria Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Lozano, Esteban Sebastián. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Sanchez, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Bruna, Flavia Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Garcia Bustos, Maria Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Sosa Lochedino, Arianna Lourdes. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Salomón, María Cristina. Universidad Nacional de Cuyo; ArgentinaFil: Fernandes, Ana Paula. Universidade Federal de Minas Gerais; BrasilFil: Mackern Oberti, Juan Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Cargnelutti, Diego Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentin